Takeda Reports $770M Write-Down, Cuts Profit Forecast by 71%...
Kate Goodwin is a freelance life science writer based in Des Moines, Iowa. She can be reached atkate.goodwin@biospace.comand onLinkedIn. MORE ON THIS TOPIC Patents Merck’s Injectable Keytruda Plans Create Legal Dispute With Halozyme:WSJ ...